This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Boostrix

GlaxoSmithKline plc

Drug Names(s): Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine

Description: BOOSTRIX is a vaccine used for booster vaccination against diphtheria, tetanus and pertussis (whooping cough) in individuals above 10 years of age. The vaccine is sometimes called Tdap vaccine. Compared to vaccines used for the primary immunization of young children, BOOSTRIX and other Tdap vaccines contain lower doses of the diphtheria and pertussis antigens.


Boostrix News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug